In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zimmer Biomet Buys LDR To Boost Spine Revenue Growth

This article was originally published in Clinica

Executive Summary

The world's second-largest orthopedic device firm, Zimmer Biomet, is making its biggest move since Zimmer and Biomet merged in 2015 with a $1bn acquisition of spine-device specialists LDR.

You may also be interested in...



M&A Analysis: Slow Month Highlighted By A Few Big Deals

Medical device mergers and acquisitions in July include LabCorps’ $371m deal for Sequenom and Zimmer Biomet’s acquisition of spine surgery robot-maker Medtech SA.

Zimmer Biomet Mirrors Medtronic's Robotics Move With Medtech SA

Zimmer Biomet will gain through a $130m deal a spine-surgery robot that may be able to compete in the emerging minimally invasive spine surgery segment. The technology will also complement Zimmer Biomet’s other recent acquisition in spine surgery devices.

Medtronic’s Prestige LP Joins LDR’s Mob-C In Two-Level Cervical Disc Competition

The US FDA approved Medtronic's artificial disc based on results of a 397-patient trial showing more favorable outcomes with Prestige LP than anterior cervical discectomy and fusion.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT034855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel